Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IGKC antibody

IGKC Reactivity: Human WB Host: Rabbit Monoclonal unconjugated
Catalog No. ABIN7267846
  • Target See all IGKC products
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Reactivity
    Human
    Host
    • 10
    • 8
    Rabbit
    Clonality
    • 11
    • 7
    Monoclonal
    Conjugate
    • 13
    • 2
    • 1
    • 1
    • 1
    This IGKC antibody is un-conjugated
    Application
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Purpose
    Human Ig Kappa Chain Rabbit mAb
    Cross-Reactivity
    Human, Mouse, Rat
    Characteristics
    Monoclonal Antibodies
    Purification
    Affinity purification
    Immunogen
    A synthesized peptide derived from human Human Ig Kappa Chain
    Isotype
    IgG
  • Application Notes
    WB,1:1000 - 1:5000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    IGKC (Immunoglobulin kappa Constant (IGKC))
    Alternative Name
    IGKC (IGKC Products)
    Synonyms
    HCAK1 antibody, IGKCD antibody, Km antibody, IGKC antibody, Igk-C antibody, immunoglobulin kappa constant antibody, immunoglobulin kappa constant L homeolog antibody, IGKC antibody, LOC708048 antibody, igkc antibody, igkc.L antibody, Igkc antibody
    Background
    Constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.,HCAK1, IGKCD, Km,Immunology & Inflammation,IGKC
    Molecular Weight
    26kDa
    Gene ID
    3514
    UniProt
    P01834
You are here:
Support